Antithrombotic and antihemolytic effects of Lagerstroemia speciosa (Lythraceae) aqueous extract [PDF]
Journal of HerbMed Pharmacology, 2022 Introduction: Aqueous extract of Lagerstroemia speciosa (EALS) (Lythraceae) is widely used to treat diabetes. This plant has been shown an in vitro thrombolytic activity that indicates its potential to prevent the formation of blood clots in vivo.
Fidèle Ziéhi Kpahé +2 more
doaj +1 more source
Effectiveness of Endophytic Bacterial Consortium of Coffee Plant on Mortality of Pratylenchus Coffeae in Vitro [PDF]
, 2015 Bacteria live in wild in form of a consortium. Use of microbial consortium tends to give better results than single isolate, because the action of enzyme of each type of microbe can complement each other in order to survive. This study aimed to study the
Giyanto, G. (Giyanto) +2 more
core +3 more sources
Isolated hemolytic anemia: an unusual manifestation of occult malignancy
Hematology Reports, 2014 Hemolysis is an uncommon and usually late complication of malignancy, and very rarely the presenting feature. Cancer-associated hemolysis may be immune-mediated, or may result from thrombotic microangiopathy accompanied by thrombocytopenia.
Matthew J. Butler, Ming Yin, Fahd Quddus
doaj +1 more source
Isohemagglutinins of Graft Origin after ABO-Unmatched Liver Transplantation [PDF]
, 1984 THE increasing success of liver transplantation in recent years has provided an experimental model to study and document the hepatic synthesis of many plasma proteins.12345 The normal hepatobiliary tract has not been regarded as a major source of ...
Anderson +13 more
core +1 more source
Bell Shape Curves of Hemolysis Induced by Silver Nanoparticles: Review and Experimental Assay
Nanomaterials, 2022 The hemolytic activity assay is a versatile tool for fast primary toxicity studies. This work presents a systematic study of the hemolytic properties of ArgovitTM silver nanoparticles (AgNPs) extensively studied for biomedical applications.
Roberto Luna-Vázquez-Gómez +9 more
doaj +1 more source
Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up [PDF]
, 2016 Primary autoimmune hemolytic anemia (P-AIHA) is a relatively uncommon and hetereogeneous disease characterized by the destruction of red blood cells due to anti-erythrocyte autoantibodies (AeAbs) in the absence of an associated disease [1–3].
ARMIENTO, DANIELE +15 more
core +1 more source
Analysis on Evaluation Method of Mechanically-Induced Hemolysis of Medical Devices
Zhongguo yiliao qixie zazhiMechanically-induced hemolysis is an important index for evaluating the blood compatibility of medical devices. It mainly evaluates the risk of mechanical hemolysis under simulated clinical use conditions of medical devices.
Jianxiu ZHU, Zhichen ZHAI
doaj +1 more source
Indian Journal of Pharmacology, 2013 Immune hemolytic anemia is a rare adverse effect of ceftriaxone, a third-generation cephalosporin, which is a commonly used antibiotic. We describe a 60-years-old lady, a case of community-acquired pneumonia, who developed severe hemolysis after the first dose of ceftriaxone. Her hemoglobin dropped from 9.6 g /dl to 5.5 g /dl.
Guleria, Vivek S. +3 more
openaire +3 more sources
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria
Emerging Infectious Diseases, 2016 Episodes of delayed hemolysis 2–6 weeks after treatment of severe malaria with intravenous artesunate have been described. We performed a prospective observational study of patients with uncomplicated malaria to investigate whether posttreatment ...
Florian Kurth +14 more
doaj +1 more source
Rapid Assessment of Relative Hemolysis Amidst Input Uncertainties in Laminar Flow
FluidsPredicting absolute values of hemolysis using the power law model to guide medical device design is hampered by uncertainties stemming from four sources of model inputs: incoming/upstream velocity profiles, blood viscosity models, power law hemolysis ...
Nasim Gholizadeh +3 more
doaj +1 more source